Policy Committee Meeting 9_28_2023

American Society for Breast Surgeons (ASBrS) Benign Breast Disease Pathways Methods 07/12/2023

Protocol • Steering Group completes top level protocol information to guide full pathway. Example protocol fields are below: Pathways Scope Surgical management of a) Atypias/high risk lesions; b) Benign fibroepithelial lesions; c) Infectious/inflammatory lesions; d) Other benign lesions Pathway Audience General and subspecialist surgeons, APPs, OB/GYN, primary care providers (internal medicine/family practice), trainees 1. Overarching Pathway Question a. What is the appropriate initial management of people with newly diagnosed benign breast disease?

i. What surgical techniques should be used based on clinical or patient characteristics? ii. What is the appropriate short-term follow-up of patients with benign breast disease?

2. Overarching Inclusion Criteria (criteria that would apply to all research questions) Per specific pathway-patients (male and female) with benign breast disease 3. Overarching Exclusion Criteria (criteria that would apply to all research questions) Evaluation of benign breast disease; Long-term follow-up (e.g., chemoprevention) Special populations: • Males with breast masses/nipple discharge

• Pregnant women • Lactating women • Young women

Method Overview The overall Pathway development process is summarized in Figure 1, and described below.